159 related articles for article (PubMed ID: 23123345)
1. A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India.
Gayen P; Nayak A; Saini P; Mukherjee N; Maitra S; Sarkar P; Sinha Babu SP
Acta Trop; 2013 Feb; 125(2):150-6. PubMed ID: 23123345
[TBL] [Abstract][Full Text] [Related]
2. Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine.
Mand S; Pfarr K; Sahoo PK; Satapathy AK; Specht S; Klarmann U; Debrah AY; Ravindran B; Hoerauf A
Am J Trop Med Hyg; 2009 Oct; 81(4):702-11. PubMed ID: 19815891
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.
Hoerauf A; Mand S; Fischer K; Kruppa T; Marfo-Debrekyei Y; Debrah AY; Pfarr KM; Adjei O; Büttner DW
Med Microbiol Immunol; 2003 Nov; 192(4):211-6. PubMed ID: 12684759
[TBL] [Abstract][Full Text] [Related]
4. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.
Taylor MJ; Makunde WH; McGarry HF; Turner JD; Mand S; Hoerauf A
Lancet; 2005 Jun 18-24; 365(9477):2116-21. PubMed ID: 15964448
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.
Turner JD; Mand S; Debrah AY; Muehlfeld J; Pfarr K; McGarry HF; Adjei O; Taylor MJ; Hoerauf A
Clin Infect Dis; 2006 Apr; 42(8):1081-9. PubMed ID: 16575724
[TBL] [Abstract][Full Text] [Related]
6. Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline.
Debrah AY; Mand S; Marfo-Debrekyei Y; Batsa L; Pfarr K; Lawson B; Taylor M; Adjei O; Hoerauf A
Am J Trop Med Hyg; 2009 Jun; 80(6):956-63. PubMed ID: 19478258
[TBL] [Abstract][Full Text] [Related]
7. Anti-Wolbachia treatment for lymphatic filariasis.
Stolk WA; de Vlas SJ; Habbema JD
Lancet; 2005 Jun 18-24; 365(9477):2067-8. PubMed ID: 15964428
[No Abstract] [Full Text] [Related]
8. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
[TBL] [Abstract][Full Text] [Related]
9. A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis.
Sanprasert V; Sujariyakul A; Nuchprayoon S
Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):800-12. PubMed ID: 21073054
[TBL] [Abstract][Full Text] [Related]
10. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
Supali T; Djuardi Y; Pfarr KM; Wibowo H; Taylor MJ; Hoerauf A; Houwing-Duistermaat JJ; Yazdanbakhsh M; Sartono E
Clin Infect Dis; 2008 May; 46(9):1385-93. PubMed ID: 18419441
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
Supali T; Ismid IS; Rückert P; Fischer P
Trop Med Int Health; 2002 Oct; 7(10):894-901. PubMed ID: 12358626
[TBL] [Abstract][Full Text] [Related]
13. Filamentation temperature-sensitive protein Z (FtsZ) of Wolbachia, endosymbiont of Wuchereria bancrofti: a potential target for anti-filarial chemotherapy.
Sharma R; Hoti SL; Vasuki V; Sankari T; Meena RL; Das PK
Acta Trop; 2013 Mar; 125(3):330-8. PubMed ID: 23262214
[TBL] [Abstract][Full Text] [Related]
14. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti.
Debrah AY; Mand S; Marfo-Debrekyei Y; Batsa L; Pfarr K; Buttner M; Adjei O; Buttner D; Hoerauf A
Trop Med Int Health; 2007 Dec; 12(12):1433-41. PubMed ID: 18076549
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
El Setouhy M; Ramzy RM; Ahmed ES; Kandil AM; Hussain O; Farid HA; Helmy H; Weil GJ
Am J Trop Med Hyg; 2004 Feb; 70(2):191-6. PubMed ID: 14993632
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of doxycycline for Mansonella perstans infection.
Coulibaly YI; Dembele B; Diallo AA; Lipner EM; Doumbia SS; Coulibaly SY; Konate S; Diallo DA; Yalcouye D; Kubofcik J; Doumbo OK; Traore AK; Keita AD; Fay MP; Traore SF; Nutman TB; Klion AD
N Engl J Med; 2009 Oct; 361(15):1448-58. PubMed ID: 19812401
[TBL] [Abstract][Full Text] [Related]
17. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.
Hoerauf A
Curr Opin Infect Dis; 2008 Dec; 21(6):673-81. PubMed ID: 18978537
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.
Debrah AY; Mand S; Specht S; Marfo-Debrekyei Y; Batsa L; Pfarr K; Larbi J; Lawson B; Taylor M; Adjei O; Hoerauf A
PLoS Pathog; 2006 Sep; 2(9):e92. PubMed ID: 17044733
[TBL] [Abstract][Full Text] [Related]
20. Anti-
Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
